Almirall

Almirall is a global pharmaceutical company focused on medical dermatology, developing and commercializing innovative prescription medicines. It addresses diverse complex skin conditions, including psoriasis, atopic dermatitis, and actinic keratosis. The company emphasizes robust research and development to discover novel therapeutic solutions for patients and healthcare professionals.

Founded in Barcelona in 1944, Almirall originated from a commitment to improving health through scientific innovation. Its establishment was driven by the insight that dedicated pharmaceutical research could significantly advance treatment for widespread medical conditions. This foundational emphasis on discovery has guided its evolution and mission for decades.

Almirall’s products serve healthcare professionals and patients globally suffering from dermatological diseases. The company's mission is to transform lives by delivering effective medicines that alleviate skin conditions. Its long-term vision focuses on pioneering further innovation within dermatology, continually expanding treatment options for better patient outcomes.